BNP Paribas Financial Markets’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $104K | Buy |
+4,630
| New | +$104K | ﹤0.01% | 3194 |
|
|
2022
Q2 | – | Sell |
-405
| Closed | -$98.1K | – | 3594 |
|
|
2022
Q1 | $98.1K | Sell |
405
-2,723
| -87% | -$660K | ﹤0.01% | 2797 |
|
|
2021
Q4 | $946K | Buy |
3,128
+3,117
| +28,336% | +$943K | ﹤0.01% | 2061 |
|
|
2021
Q3 | $4.36K | Sell |
11
-3
| -21% | -$1.19K | ﹤0.01% | 3117 |
|
|
2021
Q2 | $4.16K | Sell |
14
-79
| -85% | -$23.5K | ﹤0.01% | 3214 |
|
|
2021
Q1 | $19.1K | Sell |
93
-65
| -41% | -$13.3K | ﹤0.01% | 3198 |
|
|
2020
Q4 | $31.6K | Sell |
158
-16
| -9% | -$3.2K | ﹤0.01% | 3078 |
|
|
2020
Q3 | $28.7K | Buy |
174
+151
| +657% | +$24.9K | ﹤0.01% | 3080 |
|
|
2020
Q2 | $5.83K | Sell |
23
-173
| -88% | -$43.8K | ﹤0.01% | 3309 |
|
|
2020
Q1 | $35.7K | Buy |
196
+108
| +123% | +$19.7K | ﹤0.01% | 3098 |
|
|
2019
Q4 | $25.4K | Sell |
88
-16
| -15% | -$4.62K | ﹤0.01% | 3267 |
|
|
2019
Q3 | $28.3K | Buy |
104
+25
| +32% | +$6.8K | ﹤0.01% | 3153 |
|
|
2019
Q2 | $29.8K | Sell |
79
-56
| -41% | -$21.1K | ﹤0.01% | 3112 |
|
|
2019
Q1 | $36.2K | Buy |
+135
| New | +$36.2K | ﹤0.01% | 3092 |
|
|
2018
Q4 | – | Sell |
-21
| Closed | -$9.2K | – | 3727 |
|
|
2018
Q3 | $9.2K | Hold |
21
| – | – | ﹤0.01% | 3108 |
|
|
2018
Q2 | $8.46K | Sell |
21
-93
| -82% | -$37.5K | ﹤0.01% | 3206 |
|
|
2018
Q1 | $62.2K | Buy |
114
+17
| +18% | +$9.27K | ﹤0.01% | 2862 |
|
|
2017
Q4 | $58.3K | Buy |
97
+55
| +131% | +$33.1K | ﹤0.01% | 2920 |
|
|
2017
Q3 | $19.3K | Sell |
42
-3
| -7% | -$1.38K | ﹤0.01% | 3087 |
|
|
2017
Q2 | $18.2K | Buy |
+45
| New | +$18.2K | ﹤0.01% | 3167 |
|